Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase-Reference-Cited by-同舟云学术

Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase

Published:2003-12 Issue:12 Volume:27 Page:1091-1096
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Giles Francis J.,Feldman Eric J.,Roboz Gail J.,Larson Richard A.,Mamus Steven W.,Cortes Jorge E.,Verstovsek Srdan,Faderl Stefan,Talpaz Moshe,Beran Miloslav,Albitar Maher,O’Brien Susan M.,Kantarjian Hagop M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. Troxacitabine-based therapy of refractory leukemia;Giles;Expert Rev. Anticancer Ther.,2002

2. Anti-HIV and anti-HBV activity and resistance profile of 2′,3′-dideoxy-3′-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109;Balzarini;Biochem. Biophys Res. Commun.,1996

3. Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit replication of Epstein-Barr virus;Mar;Antiviral Res.,1995

4. (−)-2′-Deoxy-3′-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro;Coates;Antimicrob Agents Chemother,1992

5. Anticancer activity of β-l-dioxolane-cytidine, a novel nucleoside analogue with the unnatural l-configuration;Grove;Cancer Res.,1995

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Criteria for assessing the reliability of toxicity predictions: I. TIMES Ames mutagenicity model;Computational Toxicology;2021-02

2. Urinary Nucleosides and Deoxynucleosides;Advances in Clinical Chemistry;2018

3. Epigenetic Therapy With Hydralazine and Magnesium Valproate Reverses Imatinib Resistance in Patients With Chronic Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2012-06

4. Cytotoxic Nucleoside Analogues: Different Strategies to Improve their Clinical Efficacy;Current Medicinal Chemistry;2008-05-01

5. Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia;Current Opinion in Hematology;2008-03